Increased Liver Stiffness in Systemic Sclerosis: A Single-Centre Transient Elastography Study
Authors:
- Nicola OrtalliNicola Ortalli
- Alberto CivolaniAlberto Civolani
- Simone Aldo LariSimone Aldo Lari
- Emanuela VargiuEmanuela Vargiu
- Erika MeledduErika Meleddu
- Maria Maddalena AngioniMaria Maddalena Angioni
- Alberto FlorisAlberto Floris
- Sara OnaliSara Onali
- Matteo PigaMatteo Piga
- Massimo Claudio FantiniMassimo Claudio Fantini
- Alessandra VaccaAlessandra Vacca
- Alberto CauliAlberto Cauli
Open Access
- 4 November 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8593
Abstract
Background/Objectives: This study aimed to evaluate whether liver stiffness (LS), as assessed by transient elastography (TE), is increased in patients with systemic sclerosis (SSc) and to identify the factors associated with LS. Methods: In this exploratory cross-sectional study, the LS value and the prevalence of LS ≥ 5.3 and LS ≥ 7.5 kPa in 94 SSc patients and 50 healthy controls (HCs) were compared by univariate and multivariate analyses (adjusted for age and sex). TE was performed using FibroScan® and LS values were expressed in kPa. Clinical and laboratory variables were analysed as factors potentially associated with LS, LS ≥ 5.3 kPa and LS ≥ 7.5 kPa, in exploratory analyses adjusted for a pre-specified set of confounders. Results: Among the 94 SSc patients, 79 (84%) were female; median age was 59 (49–70) years, and median disease duration was 8 (3–13) years. LS was significantly higher in SSc patients than in HCs in both univariate (5.12 ± 1.95 vs. 4.18 ± 0.98 kPa, p < 0.001) and multivariate analyses (β = 0.289, p = 0.001), with a higher prevalence of LS ≥ 5.3 kPa (40.4% vs. 10.0%, adjOR 6.85, p = 0.001) and LS ≥ 7.5 kPa (11.7% vs. 0%, p = 0.009). Only a limited number of factors were associated with LS abnormalities: telangiectasias (β = 0.222, p = 0.044) and glutamic–oxaloacetic transaminase (GOT) (β = 0.278, p = 0.012) for LS, and GOT (adjOR 1.082, p = 0.020) and anti-centromere antibodies (adjOR 4.09, p = 0.017) for LS ≥ 5.3 kPa. In univariate analysis, LS ≥ 7.5 kPa was associated with pulmonary hypertension (p = 0.049), pre-capillary pulmonary hypertension (p = 0.011), and GOT (p = 0.032); no multivariate model was fitted because of the few events. Conclusions: SSc patients show increased LS values and a higher prevalence of both LS ≥ 5.3 kPa and LS ≥ 7.5 kPa than HCs, easily detectable by TE. These findings are exploratory and require confirmation in larger cohorts to determine whether increased LS in SSc reflects hepatic fibrosis and whether it carries clinical and prognostic implications.Keywords
Funding Information
- Fondazione di Sardegna (2013/1506)
- Fondazione di Sardegna (U991.2013/AI.915.MGB)
This publication has 26 references indexed in Scilit:
- Further insight into systemic sclerosis from the vasculopathy perspectiveBiomedicine & Pharmacotherapy, 2023
- Systemic Sclerosis and the LiverClinical Liver Disease, 2021
- Liver fibrosis: Pathophysiology and clinical implicationsWIREs Mechanisms of Disease, 2020
- Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and AsiaJournal of Hepatology, 2019
- Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Liver Disease, 2019
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- Liver abnormalities in connective tissue diseasesBest Practice & Research Clinical Gastroenterology, 2013
- Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracyJournal of Hepatology, 2011
- Non-invasive evaluation of liver fibrosis using transient elastographyJournal of Hepatology, 2008
- Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndromeJournal of Hepatology, 2008